Table 4.
Ref. | n (%BRAF) | End point | %BRAF MT vs %BRAF WT | P |
Tran et al[8] | 524 (11%) | Rate of peritoneal metastases | 46% vs 24% | 0.001 |
Rate of distant lymph node metastases | 53% vs 38% | 0.008 | ||
Rate of lung metastases | 35% vs 49% | 0.049 | ||
Yaeger et al[9] | 515 (18%) | Peritoneal involvement at presentation | 26% vs 14% | < 0.01 |
Kawazoe et al[12] | 264 (5%) | Peritoneal metastasis | 50% vs 18% | 0.009 |
n: Total number of patients; %BRAF: %patients with BRAF mutation; MT: Mutant; WT: Wild type.